source
- Osivax licenses GC Biopharma seasonal flu vaccine to develop combined OVX836-GC FLU shotOsivax has secured a non-exclusive license from GC Biopharma for its seasonal influenza vaccine, GC FLU, to pair with Osivax’s mid-phase candidate OVX836. OVX836 targets the conserved nucleoprotei…
- Long-term unemployment pushes many biopharma professionals to quit job searchesA recent BioSpace LinkedIn poll shows that about one-quarter of biopharma workers who have been unemployed for six months or more have stopped looking for new positions, and a similar share are con…